Rachna Khosla - 13 Sep 2021 Form 3 Insider Report for AMGEN INC (AMGN)

Role: SVP, Business Development
Signature: /s/ Rachna Khosla
Issuer symbol: AMGN
Transactions as of: 13 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 13 Sep 2021, 19:28:15 UTC
Next filing: 09 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AMGN	Common Stock						4,068	13 Sep 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AMGN	Nqso (Right to Buy)							13 Sep 2021	Common Stock	1,252	$162.60	Direct	F3
holding	AMGN	Nqso (Right to Buy)							13 Sep 2021	Common Stock	1,518	$177.46	Direct	F4
holding	AMGN	Nqso (Right to Buy)							13 Sep 2021	Common Stock	3,642	$177.31	Direct	F5
holding	AMGN	Nqso (Right to Buy)							13 Sep 2021	Common Stock	2,515	$236.36	Direct	F6
holding	AMGN	Nqso (Right to Buy)							13 Sep 2021	Common Stock	3,260	$239.64	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Equity Incentive Plan: 67 RSUs which will vest on 4/27/2022; 554 RSUs which will vest on 7/31/2022; 280 RSUs which vest in installments of 138 on 5/3/2022 and 142 on 5/3/2023; 300 RSUs which vest in two installments of 99 on 5/5/2022 and 5/5/2023 and one installment of 102 on 5/5/2024; and 375 RSUs which vest in installments of 123 on 4/30/2023, 124 on 4/30/2024 and 128 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2	These shares include 90 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3	1,252 of these non-qualified stock options have vested and are exercisable.
F4	1,001 of these non-qualified stock options have vested and are exercisable and 517 of these options will vest and become exercisable on 4/27/2022.
F5	1,201 of these non-qualified stock options have vested and are exercisable and the remaining options will vest and become exercisable in installments of 1,202 on 5/3/2022 and 1,239 on 5/3/2023.
F6	These non-qualified stock options will vest and become exercisable in three installments of 829 on 5/5/2022, 830 on 5/5/2023 and 856 on 5/5/2024.
F7	These non-qualified stock options will vest and become exercisable in three installments of 1,075 on 4/30/2023, 1,076 on 4/30/2024 and 1,109 on 4/30/2025.